248 related articles for article (PubMed ID: 43062)
21. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
Kang HJ; Shin HY; Choi HS; Ahn HS
Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
[TBL] [Abstract][Full Text] [Related]
22. [Bone marrow transplantation in leukemia and aplastic anemia].
Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
[TBL] [Abstract][Full Text] [Related]
24. [Experience in the use of allogeneic bone marrow transplantation in severe forms of aplastic anemia at the Byelorussian hematological center].
Uss AL; Zmachinskiĭ VA; Milanovich NF; Skriagin AE; Batan ZE; Dziuba EV; Mitskevich PB; Smirnova LA
Ter Arkh; 1999; 71(7):69-72. PubMed ID: 10481871
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow graft versus ALG in patients with aplastic anaemia.
Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
Biomed Pharmacother; 1983; 37(3):139-43. PubMed ID: 6357304
[TBL] [Abstract][Full Text] [Related]
27. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
[TBL] [Abstract][Full Text] [Related]
28. [Bone marrow transplantation for severe aplastic anemia].
Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
[TBL] [Abstract][Full Text] [Related]
29. Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.
Speck B; Gratwohl A; Nissen C; Leibundgut U; Ruggero D; Osterwalder B; Burri HP; Cornu P; Jeannet M
Br Med J (Clin Res Ed); 1981 Mar; 282(6267):860-3. PubMed ID: 6783204
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
[TBL] [Abstract][Full Text] [Related]
31. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
Champlin RE; Perez WS; Passweg JR; Klein JP; Camitta BM; Gluckman E; Bredeson CN; Eapen M; Horowitz MM
Blood; 2007 May; 109(10):4582-5. PubMed ID: 17272503
[TBL] [Abstract][Full Text] [Related]
33. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.
Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G
Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856
[TBL] [Abstract][Full Text] [Related]
34. Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
Kiem HP; McDonald GB; Myerson D; Spurgeon CL; Deeg HJ; Sanders JE; Doney K; Appelbaum FR; Sullivan KM; Witherspoon RP; Storb R
Biol Blood Marrow Transplant; 1996 May; 2(2):93-9. PubMed ID: 9118304
[TBL] [Abstract][Full Text] [Related]
35. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
[TBL] [Abstract][Full Text] [Related]
36. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation for severe aplastic anemia in Japan.
Kanamaru A; Nagai K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812
[TBL] [Abstract][Full Text] [Related]
38. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.
Storb R; Prentice RL; Thomas ED
J Clin Invest; 1977 Apr; 59(4):625-32. PubMed ID: 14972
[TBL] [Abstract][Full Text] [Related]
39. The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea.
Kim I; Yoon SS; Park S; Kim BK; Kim NK
J Korean Med Sci; 2003 Jun; 18(3):365-71. PubMed ID: 12808323
[TBL] [Abstract][Full Text] [Related]
40. Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia.
Giebel S; Wojnar J; Krawczyk-Kulis M; Markiewicz M; Wylezoł I; Seweryn M; Holowiecka-Goral A; Holowiecki J
Ann Transplant; 2006; 11(2):23-7; discussion 32-43. PubMed ID: 17494286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]